# A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery

> **NCT02542384** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cara Therapeutics, Inc.** · enrollment: 451 (actual)

## Conditions studied

- Post Abdominal Surgery Pain

## Interventions

- **DRUG:** CR845 IV 1 mcg/kg
- **DRUG:** CR845 IV 0.5 mcg/kg
- **DRUG:** Placebo IV

## Key facts

- **NCT ID:** NCT02542384
- **Lead sponsor:** Cara Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2018-04
- **Final completion:** 2018-06
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2019-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542384, "A Study Evaluating the Overall Pain Relief and Safety of Intravenous (IV) CR845 in Patients Undergoing Abdominal Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02542384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*